Therefore, the cyclin D-CDK4/6-Rb signaling pathway plays a critical role in cell cycle regulation, and inhibition of CDK4/6 has become an effective strategy for tumor treatment [4,5]. The gene discussed is RB1; the disease is neoplasm.